Department of Internal Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, IL 91120, Israel.
World J Gastroenterol. 2013 Jul 7;19(25):4083-6. doi: 10.3748/wjg.v19.i25.4083.
Underdiagnosis of drug-induced fever leads to extensive investigation and prolongation of hospitalization, and may lead to multiple unnecessary invasive procedures and a wrong diagnosis. Azathioprine is a widely used immunosuppressive drug. We report a case of a 53-year-old female patient diagnosed with autoimmune hepatitis treated with azathioprine, who presented to the emergency room with a 6-wk history of fever and chills without other associated symptoms. Since the patient's fever was of unknown origin, she was hospitalized. All treatment was stopped and an extensive workup to explore the source of fever and chills was performed. Results of chest X-ray, viral, urine, and blood cultures, autoimmune serology, transthoracic and transesophageal echocardiography, and abdominal ultrasound revealed no source of infection. A rechallenge test of azathioprine was performed and the fever and chills returned within a few hours. Azathioprine was established as the definite cause following rechallenge. Fever as an adverse drug reaction is often unrecognized. Azathioprine has been reported to cause drug-induced fever in patients with inflammatory bowel disease, rheumatoid arthritis, and sarcoidosis. To the best of our knowledge there have been no previous reports documenting azathioprine-induced fever in patients with autoimmune hepatitis. The occurrence of fever following the readministration of azathioprine suggests the diagnosis of drug-induced fever, particularly after the exclusion of other causes. A careful rechallenge is recommended to confirm the diagnosis.
药物引起的发热诊断不足会导致广泛的检查和住院时间延长,并可能导致多次不必要的侵入性操作和误诊。巯嘌呤是一种广泛应用的免疫抑制剂。我们报告了一例 53 岁女性患者,自身免疫性肝炎应用巯嘌呤治疗后,因发热、寒战 6 周就诊,无其他相关症状。由于患者发热原因不明,故住院治疗。所有治疗均被停止,并进行了广泛的检查以寻找发热和寒战的原因。胸部 X 线、病毒、尿液和血液培养、自身免疫血清学、经胸和经食管超声心动图以及腹部超声均未发现感染源。对患者进行了巯嘌呤再激发试验,几小时内再次出现发热和寒战。再激发后确定了巯嘌呤是明确的病因。发热作为一种药物不良反应,常常未被识别。巯嘌呤已被报道可引起炎症性肠病、类风湿关节炎和结节病患者的药物相关性发热。据我们所知,以前没有关于自身免疫性肝炎患者应用巯嘌呤引起发热的报道。在重新给予巯嘌呤后出现发热提示药物相关性发热的诊断,尤其是在排除其他病因后。建议仔细再激发以确认诊断。